M&A Deal Summary |
|
|---|---|
| Date | 2019-07-18 |
| Target | Quotient Sciences |
| Sector | Life Science |
| Buyer(s) | Permira |
| Sellers(s) | GHO Capital Partners |
| Deal Type | Recapitalization |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 80.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Permira is a mega-sized private equity firm that targets large company investments around the world. Permira invests to support acquisitions, leveraged buyouts, take-privates, turnarounds, and growth buyouts. Areas of interest include healthcare, financial services, chemicals, consumer products and services, industrial products and services, technology, media, and telecom. Permira will consider opportunities in Europe, Asia, and North America. Permira was formed in 1985 and has offices in Menlo Park, Frankfurt, Luxembourg, London, Hong Kong, Madrid, Milan, Paris, Stockholm, Tokyo, Guernsey and New York City.
| DEAL STATS | # |
|---|---|
| Overall | 129 of 170 |
| Sector: Life Science M&A | 2 of 7 |
| Type: Recapitalization M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 30 of 34 |
| Year: 2019 M&A | 3 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-10 |
Reformation
Los Angeles, California, United States Reformation is a digitally-led women’s contemporary apparel brand. The company puts sustainability at the core of everything it does, from materials innovation to its sustainable partner factories around the world. Reformation was founded in 2009 and is based in Los Angeles, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-07 |
Cambrex
East Rutherford, New Jersey, United States Cambrex is a life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapeutics. Cambrex was formed in 1981 and is headquartered in East Rutherford, New Jersey. |
Buy | $2.4B |
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 5 |
| Sector: Life Science M&A | 1 of 5 |
| Type: Recapitalization M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-12 |
Sterling Pharma Solutions
Northumberland, United Kingdom Sterling Pharma Solutions is a provider of API development and manufacturing. Sterling delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle. Sterling Pharma Solutions is based in Northumberland, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-31 |
CellCarta
Montreal, Quebec, Canada CellCarta is a provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. CellCarta was founded in 2000 and is based in Montreal, Quebec. |
Sell | - |
